| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |